Literature DB >> 6281392

The relationship between anti-acetylcholine receptor antibody levels and neuromuscular function in chronically myasthenic rats.

P E Gallant.   

Abstract

Rats immunized with acetylcholine receptor protein (AChR) purified from Torpedo electric organ develop defects of neuromuscular function closely mimicking those of myasthenia gravis. These rats are easily fatigued, have reduced neuromuscular transmission, and high titers of anti-AChR antibody. Contrary to previous findings however, the present study finds a very good correlation between the development of the anti-rat AChR antibody levels and subsequent decreases in neuromuscular function in experimentally myasthenic animals. This result supports the hypothesis that anti-AChR antibody levels play a central role in development of experimental myasthenia. The relevance of these findings to the pathology of myasthenia gravis is considered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281392     DOI: 10.1016/0022-510x(82)90225-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Reversible Recruitment of a Homeostatic Reserve Pool of Synaptic Vesicles Underlies Rapid Homeostatic Plasticity of Quantal Content.

Authors:  Xueyong Wang; Martin J Pinter; Mark M Rich
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

2.  Homeostatic Plasticity of the Mammalian Neuromuscular Junction.

Authors:  Kathrin L Engisch; Xueyong Wang; Mark M Rich
Journal:  Adv Neurobiol       Date:  2022

3.  The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.

Authors:  J J Plomp; G T van Kempen; P C Molenaar
Journal:  J Physiol       Date:  1994-07-01       Impact factor: 5.182

Review 4.  Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.

Authors:  Xueyong Wang; Mark M Rich
Journal:  Ann N Y Acad Sci       Date:  2017-10-05       Impact factor: 5.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.